Ardelyx (ARDX) reported $73.22 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 227.9%. EPS of -$0.07 for the same period compares to -$0.08 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $55.73 million, representing a surprise of +31.38%. The company delivered an EPS surprise of +30.00%, with the consensus EPS estimate being -$0.10.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Ardelyx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Product sales, net

  : $72.59 million versus $53.87 million estimated by six analysts on average.

• Revenues- Product supply

  : $0.01 million versus $2.60 million estimated by three analysts on average.

• Revenues- Licensing

  : $0.02 million versus the two-analyst average estimate of $0.35 million.

View all Key Company Metrics for Ardelyx here>>>

Shares of Ardelyx have returned +4.3% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ardelyx, Inc. (ARDX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research